Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methy1-4-phenylisoxazole (P6)

被引:73
作者
Cingolani, Gino [1 ,2 ]
Panella, Andrea [3 ]
Perrone, Maria Grazia [3 ]
Vitale, Paola [3 ]
Di Mauro, Giuseppe [4 ]
Fortuna, Cosimo G. [4 ]
Armen, Roger S. [5 ]
Ferorelli, Savina [3 ]
Smith, William L. [6 ]
Scilimati, Antonio [3 ]
机构
[1] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA
[2] CNR, Inst Biomembranes & Bioenerget, Via Amendola 165-A, I-70125 Bari, Italy
[3] Univ Bari Aldo Moro, Dept Pharm Pharmaceut Sci, Via E Orabona 4, I-70125 Bari, Italy
[4] Univ Catania, Dept Sci Chim, Viale Andrea Doria 6, I-95125 Catania, Italy
[5] Thomas Jefferson Univ, Dept Pharmaceut Sci, Coll Pharm, Philadelphia, PA 19107 USA
[6] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA
关键词
Cyclooxygenase-1; inhibition; Mofezolac; P6; Diarylisoxazole; X-ray crystallography; Molecular modelling; CRYSTAL-STRUCTURE; SYNTHASE-1; DESIGN; SITE;
D O I
10.1016/j.ejmech.2017.06.045
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The diarylisoxazole molecular scaffold is found in several NSAIDs, especially those with high selectivity for COX-1. Here, we have determined the structural basis for COX-1 binding to two diarylisoxazoles: mofezolac, which is polar and ionizable, and 3-(5-chlorofuran-2-y1)-5-methyl-4-phenylisoxazole (P6) that has very low polarity. X-ray analysis of the crystal structures of COX-1 bound to mofezolac and 3-(5chlorofuran-2-yl)-5-methyl-4-phenylisoxazole allowed the identification of specific binding determinants within the enzyme active site, relevant to generate structure/activity relationships for diarylisoxazole NSAIDs. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:661 / 668
页数:8
相关论文
共 40 条
[1]   PHENIX:: building new software for automated crystallographic structure determination [J].
Adams, PD ;
Grosse-Kunstleve, RW ;
Hung, LW ;
Ioerger, TR ;
McCoy, AJ ;
Moriarty, NW ;
Read, RJ ;
Sacchettini, JC ;
Sauter, NK ;
Terwilliger, TC .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :1948-1954
[2]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[3]   A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): Theory and application [J].
Baroni, Massimo ;
Cruciani, Gabriele ;
Sciabola, Simone ;
Perruccio, Francesca ;
Mason, Jonathan S. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (02) :279-294
[4]   Highly Selective Cyclooxygenase-1 Inhibitors P6 and Mofezolac Counteract Inflammatory State both In Vitro and In Vivo Models of Neuroinflammation [J].
Calvello, Rosa ;
Lofrumento, Dario Domenico ;
Perrone, Maria Grazia ;
Cianciulli, Antonia ;
Salvatore, Rosaria ;
Vitale, Paola ;
De Nuccio, Francesco ;
Giannotti, Laura ;
Nicolardi, Giuseppe ;
Panaro, Maria Antonietta ;
Scilimati, Antonio .
FRONTIERS IN NEUROLOGY, 2017, 8
[5]  
DeLano WL., 2002, PYMOL MOL GRAPHICS S
[6]   Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: Reversal cyclooxygenase-2 selectivity by sulfonamide group removal [J].
Di Nunno, L ;
Vitale, P ;
Scilimati, A ;
Tacconelli, S ;
Patrignani, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (20) :4881-4890
[7]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[8]   Analgesic effect of mofezolac, a non-steroidal anti-inflammatory drug, against phenylquinone-induced acute pain in mice [J].
Goto, K ;
Ochi, H ;
Yasunaga, Y ;
Matsuyuki, H ;
Imayoshi, T ;
Kusuhara, H ;
Okumoto, T .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1998, 56 (04) :245-254
[9]   Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities [J].
Grosser, T ;
Fries, S ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) :4-15
[10]   The 2.0 A resolution crystal structure of prostaglandin H2 synthase-1:: Structural insights into an unusual peroxidase [J].
Gupta, K ;
Selinsky, BS ;
Kaub, CJ ;
Katz, AK ;
Loll, PJ .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 335 (02) :503-518